Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET –rearranged thyroid cancer is a research paper published in The Journal of Experimental Medicine (2022). On theSindex it has a DataRank of 0.761. It has been cited 18 times, with 18 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.442
From this paper's citation signal
Citation Network Contribution
0.319
From 15 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 18 citers.
National Institutes of Health
Grant: R21 CA2022540
NCI NIH HHS
Grant: R21 CA202540
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals